Current practices in managing end-of-life existential suffering.
Michelle Di Risio, Alison Thompson
Current opinion in supportive and palliative care June 1, 2023 DOI: 10.1097/SPC.0000000000000646 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Population | Palliative care patients experiencing existential suffering at the end of life |
| Interventions | brain stimulation psychedelics palliative sedation lethal injections |
| Citations | 5 |
| Key findings | Newer approaches such as brain stimulation and psychedelics show promise for addressing existential suffering in palliative care, but palliative sedation and lethal injections remain ethically controversial and lack a clear clinical definition of ES. |
Abstract
Within the context of palliative care, existential suffering (ES) can be an exclusive source of suffering or intertwined with physical pain and/or psychological and spiritual suffering. With newly emerging modalities for addressing this phenomenon and its increasing salience given that many patients cite ES as a significant contributing factor to requests for hastened death, a review of recent interventions for addressing ES at the end of life is timely. This review of newer approaches to dealing with ES in the palliative context suggests some promising new modalities and pharmacological interventions, such as brain stimulation and the use of psychedelics. The use of other pharmacological interventions, such as palliative sedation and lethal injections, solely for the alleviation of existential distress remains ethically controversial and difficult to disentangle from other forms of suffering, not least because a clear clinical definition of ES has yet to emerge in the literature. The evaluation of end-of-life (EOL) ES mitigating tools should also consider how broader contexts, such as institutional arrangements and barriers, and cultural factors may influence the optimal management of dying persons' ES in the palliative care setting.
Citations in the library
Cited by 2
- Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care Palliative Medicine Reports April 17, 2025
- Feuille de route pour un accès équitable et une utilisation responsable de la psychothérapie assistée par la psilocybine dans les soins palliatifs Cahiers francophones de soins palliatifs 2026
Cites 5
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Journal of Psychopharmacology January 9, 2020
- Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics Psychopharmacology November 29, 2019
- Psilocybin mushrooms for psychological and existential distress Canadian Family Physician November 1, 2022
- Psychedelics for Psychological and Existential Distress in Palliative and Cancer Care Current Oncology August 1, 2019